On 21 February 2026, stepping off a flight and landing in Kerala, I weighed close to 100 kilograms and was managing nine medications for conditions that had followed a serious cardiac event in 2023, one I was still, in meaningful ways, recovering from. I had lost my mother fifteen months earlier, and was still grieving. Two months later, on 23 April, I incorporated Latif Strategic Advisory.
I am telling you this not as context for a transformation story, but as a baseline. What followed over the next twenty-two weeks was a health transformation built on clinical protocol, medication, and structured tracking. Not willpower alone. Simultaneously, a specialist advisory firm was taking shape in one of the harder segments of life sciences strategy. By July: approximately 21 kilograms gone, more than 21% of body weight, with body fat at approximately 17%. The medication count had fallen from nine to six. Type 2 diabetes, formally in remission. Blood pressure normalised. The firm had its first major client engagement, thirteen weeks after incorporation.
I am not writing this to report those numbers. I am writing this because running both projects at the same time taught me something I did not expect: the same operating discipline drove both. The transfer between them was not accidental. It was structural.
The substrate is the same person
Operating discipline is not a set of habits applied separately to health, work, and relationship. It is one integrated system running on one substrate: the person doing the operating. That substrate either functions or it doesn't, and the effects propagate across every domain it touches.
I had a version of this insight in the abstract before February. Running the experiment in two domains simultaneously, with data, made it concrete. When my sleep was good, my commercial judgment was sharper. When my blood glucose was stable, my patience in difficult conversations was longer. When my energy was depleted (genuinely depleted, not just tired), I made worse decisions about which opportunities to pursue and which to let go. These correlations were consistent, measurable, and once I understood them, manageable.
"The most leveraged investment is not in the firm. It is in the operating capacity of the person building it."
The same propagation runs in other directions too. My closest relationships initially suffered: not from neglect, but from absence. Depleted energy means depleted presence, and presence is what relationships actually run on. As the substrate improved, so did the quality of attention I could bring to the people who matter. Those relationships are now, in several cases, deeper than they were before the firm started. I didn't expect that. In retrospect, I should have.
Instrument yourself before you instrument your firm
The first thing I did in February was build a measurement system for my own physiology. The objective layer was an Oura ring: resting heart rate, heart rate variability, sleep quality staged and scored each night automatically. The subjective layer was an Excel spreadsheet I built alongside it — twelve variables logged every morning, including energy level, mood, cognitive load, emotional load, blood pressure, and a short qualitative note on how the day actually felt. The whole framework takes under two minutes to complete. At the end of each week, I ran the combined data through Claude to surface patterns across the rows I hadn't caught manually. After a few weeks, things became visible that had never been visible before. Not because the system was sophisticated. Because I had never looked systematically.
The methodology is not complex, and I want to be clear about that. A wearable, a spreadsheet, and a language model are accessible to anyone with some thought and patience. What I applied was something different: the same analytical rigour I had spent twenty years deploying on client problems, turned inward. The same insistence on signal over noise. The same intolerance for data that doesn't actually inform a decision. The same habit of asking what's structural and what's artefact. Most people don't instrument themselves this way because it feels unusual to treat yourself as the case. Once I framed it as a consulting engagement with a single client, the methodology followed naturally.
The trained capacity to read internal signals accurately — and what it has to do with commercial judgment.
What develops with consistent physiological tracking is something clinicians call interoception: the ability to read internal signals accurately and act on them before they become obvious. Experienced practitioners develop a functional equivalent for external situations — reading what a client dynamic is signalling before it becomes explicit, what a market shift means before the data firms up. Both are pattern recognition systems operating on incomplete information. Both can be calibrated. And both degrade when the underlying instrument is running on poor sleep, unstable metabolism, and depleted attention.
The skill required to distinguish a 0.4-kilogram weight spike caused by water retention from one caused by genuine dietary excess is structurally similar to the skill required to read a client situation accurately: you are looking for signal in a noisy environment, distinguishing real information from artefact, and calibrating your response accordingly. Both reward patience. Both punish reactivity.
Most people preparing to start a business invest in market research, competitive analysis, stakeholder mapping. Almost no one invests in accurately calibrating their own perceptual state. That is a mistake, because the instrument doing all the reading is the same person in both cases. If it is uncalibrated or degraded, everything downstream is degraded with it.
Deposits and withdrawals
In the early months of building LSA, revenue was limited. That was expected and planned for. What I was building instead, deliberately and without urgency, was the deposit base.
Thought leadership pieces that found audiences I hadn't anticipated. Senior conversations across the industry deepening into genuine peer relationships. The early architecture of a diversified portfolio: consulting mandates with clinical-stage biotechs navigating HTA and evidence decisions; advisory relationships with PE firms investing seriously in life sciences; strategic partnerships that extend analytical capacity without compromising independence; and the early formation of a Tier-1 expert advisory panel of people whose credibility I respected and who engaged on substance. None of these are revenue. All of them are deposits: compounding assets that arrive quietly, accumulate slowly, and pay out later in step-functions.
Revenue, recognition, and referrals are withdrawals. Most founders, under pressure, try to accelerate withdrawals before the deposit base is sufficient to support them. The result is a firm with clients before it has positioning, with revenue before it has a methodology, with activity before it has operating discipline. The sequence matters enormously.
"Being aggressive on deposits and patient on withdrawals is the winning ratio. It is also, genuinely, the harder one to hold when nothing visible is happening yet."
The same logic governs physiology. The adaptations that brought my cardiovascular baseline down to the low fifties required twenty-plus weeks of consistent stimulus. They did not happen faster because I wanted them to. A non-linear biological system does not compress its timeline under urgency. The deposit is what creates the withdrawal capacity.
The invisible middle
Between weeks eight and sixteen, almost nothing visible happened. The weight had stabilised. Not because the protocol had failed, but because the composition was shifting beneath the number: fat reducing, muscle holding, metabolic markers improving below a surface that looked flat. On the firm side, the same period: conversations progressing, frameworks developing, relationships deepening. No signed work yet.
This phase (I've started calling it the invisible middle) is where most founders and most patients abandon the protocol. The absence of visible output reads as evidence the system isn't working. It usually isn't. In non-linear systems, the invisible middle is the phase in which compounding is happening beneath the surface. The outputs simply haven't crossed the threshold of visibility yet.
The discipline required here is not motivation.
It is understanding that non-linear systems respond in bursts after periods of invisible accumulation, and that the appropriate response is to hold the protocol. Not intensify it out of frustration, or abandon it out of doubt.
Three data streams
Weight alone misled me, repeatedly. There were mornings when the scale showed a rise and everything else (energy, mental clarity, how my clothes fitted) was pointing upward. The discrepancy was signal, not contradiction: muscle gain was masking fat loss, training load was creating temporary water retention above real metabolic progress. Acting on the weight number alone would have produced the wrong response.
The Three-Stream Framework
The commercial equivalent is familiar. Client signals alone mislead: what a client says they want and what their organisation will commit to are often different data. Market intelligence alone misleads. A signal can be real and still irrelevant to your specific positioning. Revenue as lagged feedback is ground truth but arrives too slowly to guide weekly decisions. Waiting for convergence across all three is slower than acting on one. It is considerably more accurate.
Managing the operator
The founder is the bottleneck. Not as criticism. As structural fact. Strategy, judgment, client relationships, positioning, business development: all run through one person. When that person's judgment degrades, so does every output.
By March, I had enough data to know that my cognitive clarity correlated tightly with sleep quality, daily movement, and metabolic stability. This was not guesswork. It was consistent and measurable. The implications for how I structured my week followed directly: when I scheduled demanding client conversations, when I did analytical work, how I protected the mornings. Small decisions, compounding.
Protecting the operator's cognitive state is not self-indulgence. It is the highest-leverage activity available to an early-stage firm. The most commercially important investment I made in the first half of this year was not in business development. It was in the sleep and recovery that kept my judgment functional during the weeks when the firm's first significant conversations were live.
Deprescribing
By July, I was on six medications instead of nine. Three had been removed, not by overriding clinical guidance, but because the underlying system had changed and no longer needed them.
One of those reductions was not a planned milestone. It was a correction. The anti-hypertensive dose that had been appropriate at close to 100 kilograms was, several months into the transformation, too much. Blood pressure had normalised faster than anyone anticipated. On the higher dose, it was going too low: dizziness on standing, a couple of days of unexplained fatigue, a sense that something was off before I could identify why. The medication was reduced. The body had changed faster than the protocol had been updated to reflect.
That episode (mundane in clinical terms, genuinely instructive in operating terms) illustrates what deprescribing actually signals. It is not simplification for its own sake. It is evidence that the underlying structure has strengthened to the point where the scaffolding has become unnecessary, or in this case, counterproductive. Done at the wrong moment, removing support is risk. Done at the right one, it is confirmation.
Firms work the same way. Service lines, processes, partnerships, communication architecture: all accumulate complexity over time. The moment you can genuinely simplify (not because you are cutting corners but because the underlying capability now operates without the scaffolding) is a milestone. Knowing which phase you are in requires honest assessment of what is actually holding the structure up.
The same logic extends beyond the firm. Building LSA has accelerated a clarification I was not expecting: where my time and attention belong, and where they don't. Not every relationship, obligation, or opportunity that existed before the firm is still load-bearing. The situations that drain rather than fuel, the commitments built on habit rather than meaning, the opportunities that look relevant but don't actually align with what LSA stands for: all of these are now evaluated with more honesty and less tolerance than before. Not from ruthlessness. From a clearer reading of what the underlying system can support.
"De-prioritising is not a founder personality trait. It is an operating discipline. Knowing what not to chase is, if anything, harder to build than knowing what to pursue."
And like clinical deprescribing, it feels like loss until you realise the system is running cleaner without it.
What transfers, and what is still being built
Twenty-two weeks, two domains, one operating model. These results are real, but it is early. LSA is fourteen weeks old. The health transformation is twenty-two weeks in. Both are past the phase of invisible accumulation, into the phase where the model is beginning to confirm itself, but neither is finished, and I am under no illusion that what has been built is durable without continued investment in the deposits.
Not everything has kept pace. I have been trying, and mostly failing, to maintain my Arabic classes alongside everything else. That is a small thing in the scheme of what has changed. But it is an honest one. Transformation in one domain does not automatically protect every other commitment. Some things slip. Knowing which to recover, and which to set down for now, is itself a form of operating discipline.
What I can say with some confidence: the discipline transfers. A first major client engagement at thirteen weeks. A pipeline developing across different client types. A small but growing expert advisory panel. Important strategic partnerships forming with people whose frameworks complement rather than duplicate mine. A portfolio beginning to diversify across clinical-stage biotechs, PE firms with serious infrastructure, and delivery partnerships that extend what LSA can do without compromising what it stands for. The deposits, compounding.
The shape of what is being built matters as much as the components. Taken together, these elements constitute something closer to a network orchestrator than a traditional boutique: a signal-detection architecture capable of reading across markets, payer systems, and policy environments simultaneously, and routing what it finds to the right analytical frame. That mirrors, more than coincidentally, the same pattern recognition I was building into my understanding of my own physiology. Interoception, externalised.
The substrate is the same person. That is the only leverage point that touches everything else. It is also the one most consistently under-invested by founders who treat physical and cognitive capacity as inputs to be consumed rather than infrastructure to be maintained.
Running the experiment in two domains simultaneously was not a choice I would have made by design. It was the situation I was in: building a firm while recovering from a cardiac event, grieving a parent, and attempting to reverse a decade of metabolic decline. The convergence, the moment when the health data and the commercial data started confirming the same underlying principles, was the most convincing evidence I have encountered that operating discipline genuinely transfers.
The domain changes. The substrate does not.